Home

Andrea Paul

CIK 1863130 · Chief Legal Officer · last filed 2025-02-05

Andrea Paul is a Chief Legal Officer who has filed 8 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for ZNTL, was dated Feb 5, 2025. Across all open-market trades the lifetime net is −$60.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.95M

Companies

2

Total Filings

8

Lifetime Open-Market Net

-$60.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ZNTL Chief Legal Officer 1,070,784 $4.62 $4.95M -$60.8K 4 2025-02-05
LogicBio Therapeutics, Inc. (LOGC) Delisted General Counsel and Secretary — $7.06 — $0 2 2022-03-03

Recent Filings

8 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-02-05 ZNTL Mixed +920,811 -$22.6K EDGAR
2025-02-03 ZNTL Notice (144) −13,230 -$22.6K EDGAR
2024-02-05 ZNTL Mixed +109,190 -$38.2K EDGAR
2024-02-02 ZNTL Notice (144) −3,310 -$38.2K EDGAR
2023-02-01 ZNTL Grant (A) +40,783 $0 EDGAR
2022-08-01 ZNTL Grant (A) — $0 EDGAR
2022-03-03 LogicBio Therapeutics, Inc. (LOGC) Delisted Grant (A) — $0 EDGAR
2021-05-19 LogicBio Therapeutics, Inc. (LOGC) Delisted Grant (A) — $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.